Scofield M D, Heinsbroek J A, Gipson C D, Kupchik Y M, Spencer S, Smith A C W, Roberts-Wolfe D, Kalivas P W
Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina (M.D.S., J.A.H., S.S., D.R.-W., P.W.K.); Department of Psychology, Arizona State University, Tempe, Arizona (C.D.G.); Department of Neuroscience, Hebrew University, Jerusalem, Israel (Y.M.K.); and Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York (A.C.W.S.)
Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina (M.D.S., J.A.H., S.S., D.R.-W., P.W.K.); Department of Psychology, Arizona State University, Tempe, Arizona (C.D.G.); Department of Neuroscience, Hebrew University, Jerusalem, Israel (Y.M.K.); and Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York (A.C.W.S.).
Pharmacol Rev. 2016 Jul;68(3):816-71. doi: 10.1124/pr.116.012484.
The nucleus accumbens is a major input structure of the basal ganglia and integrates information from cortical and limbic structures to mediate goal-directed behaviors. Chronic exposure to several classes of drugs of abuse disrupts plasticity in this region, allowing drug-associated cues to engender a pathologic motivation for drug seeking. A number of alterations in glutamatergic transmission occur within the nucleus accumbens after withdrawal from chronic drug exposure. These drug-induced neuroadaptations serve as the molecular basis for relapse vulnerability. In this review, we focus on the role that glutamate signal transduction in the nucleus accumbens plays in addiction-related behaviors. First, we explore the nucleus accumbens, including the cell types and neuronal populations present as well as afferent and efferent connections. Next we discuss rodent models of addiction and assess the viability of these models for testing candidate pharmacotherapies for the prevention of relapse. Then we provide a review of the literature describing how synaptic plasticity in the accumbens is altered after exposure to drugs of abuse and withdrawal and also how pharmacological manipulation of glutamate systems in the accumbens can inhibit drug seeking in the laboratory setting. Finally, we examine results from clinical trials in which pharmacotherapies designed to manipulate glutamate systems have been effective in treating relapse in human patients. Further elucidation of how drugs of abuse alter glutamatergic plasticity within the accumbens will be necessary for the development of new therapeutics for the treatment of addiction across all classes of addictive substances.
伏隔核是基底神经节的主要输入结构,整合来自皮质和边缘系统结构的信息,以介导目标导向行为。长期接触几类滥用药物会破坏该区域的可塑性,使与药物相关的线索产生寻求药物的病理动机。在从长期药物暴露中戒断后,伏隔核内谷氨酸能传递会发生一些改变。这些药物诱导的神经适应性变化是复发易感性的分子基础。在本综述中,我们聚焦于伏隔核中的谷氨酸信号转导在成瘾相关行为中所起的作用。首先,我们探讨伏隔核,包括其中存在的细胞类型和神经元群体以及传入和传出连接。接下来,我们讨论成瘾的啮齿动物模型,并评估这些模型用于测试预防复发的候选药物疗法的可行性。然后,我们综述文献,描述滥用药物和戒断后伏隔核中的突触可塑性是如何改变的,以及伏隔核中谷氨酸系统的药理学操纵如何在实验室环境中抑制药物寻求行为。最后,我们研究临床试验的结果,其中旨在操纵谷氨酸系统的药物疗法已有效治疗人类患者的复发。进一步阐明滥用药物如何改变伏隔核内的谷氨酸能可塑性,对于开发针对所有成瘾物质类别的成瘾治疗新疗法将是必要的。